Clinic
DRX Paramus, LLC
DRX Paramus, LLC was paid $3.08M by Medicaid between Dec 2018 and Nov 2024, across 38 billing codes. Its largest line is S9083, Global fee urgent care centers — 39% of everything it billed.
33Billing provider infoDRX PARAMUS, LLC
PARAMUS, NJ 07652
PARAMUS, NJ 07652
33aNPI1316272685assigned 10/05/2009
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.08M
24GClaims70,206
24DCodes billed38
24AFirst – last monthDec 2018 – Nov 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in New Jersey
Rank by total paid#9 of 60
Median peer was paid$255K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15 | $1K | |
| 2023 | 18,149 | $834K | |
| 2024incomplete | 52,042 | $2.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 39% | 13,974 | 12,325 | $1.20M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 8,002 | 7,293 | $421K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13% | 6,092 | 5,768 | $415K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 7,189 | 6,810 | $335K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 7,399 | 6,726 | $285K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.2% | 8,151 | 7,485 | $252K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 8,133 | 3,957 | $81K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 5,445 | 5,144 | $54K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 172 | 161 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 118 | 112 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 51 | 49 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 190 | 181 | $3K |
26 more codes
| 81025 | <1% | 625 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 17 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 463 | $2K |
| 73610 | <1% | 169 | $2K | |
| 73630 | <1% | 147 | $2K | |
| 81003 | <1% | 1,567 | $2K | |
| 93000 | <1% | 155 | $1K | |
| 73130 | <1% | 45 | $484.09 | |
| 90715 | <1% | 13 | $370.91 | |
| 73110 | <1% | 35 | $345.00 | |
| 73140 | <1% | 29 | $320.32 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 43 | $299.92 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 181 | $298.84 |
| 36415 | Collection of venous blood by venipuncture | <1% | 114 | $295.62 |
| 73562 | <1% | 26 | $275.97 | |
| 69209 | <1% | 31 | $202.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 81 | $127.40 |
| 99000 | <1% | 378 | $78.52 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 25 | $43.61 |
| 99051 | <1% | 834 | $30.00 | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 21 | $28.50 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 41 | $15.29 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 22 | $1.30 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 178 | $1.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 30 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALIZIA, ROBERT (MEDICAL DIRECTOR / OWNER)
| Provider | Location | Paid |
|---|---|---|
| Christiana Care Quality Partners | Elkton, MD | $661K |
| Christiana Care Quality Partners | North East, MD | $354K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.